ad

4 Midcap Promoter Backed Fast Revenue Growth and Profit CAGR Stocks to Watch for Future Multibagger Potential: Nippon AMC, Oberoi Realty, Narayana Health and Endurance

Nippon AMC Rs 1,088. Oberoi Realty Rs 1,744.30. Narayana Health Rs 1,866.40. Endurance Rs 2,527.60. Market caps from Rs 36,097 crore to Rs 75,647 crore. Data as of 11 Nov 2026.


12 Nov 2026 • 1:54 pm

4 Midcap Promoter Backed Fast Revenue Growth and Profit CAGR Stocks to Watch for Future Multibagger Potential: Nippon AMC, Oberoi Realty, Narayana Health and Endurance

Quick Answer

Nippon AMC, Oberoi Realty, Narayana Health and Endurance are the 4 picks in this promoter backed fast revenue growth and profit CAGR stocks watchlist, with market caps between Rs 36,097 crore and Rs 75,647 crore. Nippon AMC stands out for the highest return on equity at 32.83%, while Oberoi Realty offers the fastest profit growth, 24.40% a year since FY22. PE ratios run from 24.95 to 46.24, so compare each one with its industry PE before investing. All figures are as of 11 November 2026.

Promoter backed fast revenue growth and profit CAGR stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Nippon AMC, Oberoi Realty, Narayana Health and Endurance meet that test, with market caps from Rs 36,097 crore to Rs 75,647 crore and Nippon AMC offering the highest return on equity at 32.83%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a promoter holding of at least 50 per cent, FY26 revenue growth of at least 15 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a promoter holding of at least 50 per cent, FY26 revenue growth of at least 15 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening promoter backed fast revenue growth and profit CAGR stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 11 November 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Promoter Backed Fast Revenue Growth and Profit CAGR Stocks and Why Do They Attract Multibagger Interest?

Promoter backed fast revenue growth and profit CAGR stocks are shares of mid sized companies in which the promoters own at least half of the business, whose sales grew by fifteen per cent or more in FY26 and whose profit has compounded at fifteen per cent or more a year over four years. The four here cover asset management, real estate, auto components and hospitals.

Owners with a large stake have their own wealth tied to the company, fast sales growth shows demand, and a four year profit record shows that earnings have grown steadily and not on one good year. Within promoter backed fast revenue growth and profit CAGR stocks, the four companies show rising profit. In promoter backed fast revenue growth and profit CAGR stocks, each of the four also posted growth in the latest quarter. Across promoter backed fast revenue growth and profit CAGR stocks, every company here grew its FY26 profit. For promoter backed fast revenue growth and profit CAGR stocks, both FY26 and the latest quarter showed growth. Whichever way you read promoter backed fast revenue growth and profit CAGR stocks, the common thread is rising profit backed by complete financial data. With promoter backed fast revenue growth and profit CAGR stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for promoter backed fast revenue growth and profit CAGR stocks are complete. Read each company's latest results and exchange filings before acting on promoter backed fast revenue growth and profit CAGR stocks.

Promoter Backed Fast Revenue Growth and Profit CAGR Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 11 November 2026. Oberoi Realty has the lowest PE of the group at 24.95, while Nippon AMC posts the highest return on equity at 32.83%.

Stock CMP (Rs) Market Cap (Rs Cr) PE Industry PE ROE Debt to Equity 52-Week Range (Rs)
Nippon Life India Asset Management 1,088 75,647 46.21 17.70 32.83% 0.02 795.80 to 1,269.50
Oberoi Realty 1,744.30 65,583 24.95 31.94 13.99% 0.16 1,391.20 to 1,986.10
Narayana Hrudayalaya 1,866.40 37,763 46.24 60.75 17.76% 1.29 1,589.00 to 2,093.30
Endurance Technologies 2,527.60 36,097 37.22 37.33 13.91% 0.19 2,142.80 to 3,072.00

Nippon AMC: Return on Equity of 32.83%

Nippon Life India Asset Management is one of the largest mutual fund houses in India and also runs ETFs and portfolio management services. It reported FY26 revenue of Rs 2,933.07 crore, up 16.36% year on year, and net profit of Rs 1,528.13 crore, up 18.85%. Net profit has compounded at 19.74% a year since FY22, while revenue has grown 17.56% a year. Operating margin was 68.84% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.

In the June 2026 quarter, revenue rose 24.51% to Rs 937.08 crore and net profit grew 27.15% to Rs 503.09 crore. The share price has gained 155.40% over five years and 32.72% over the past year. Domestic institutions raised their holding from 13.45% in June 2025 to 15.49% in June 2026. The stock trades at a PE of 46.21 against an industry PE of 17.70, with a return on equity of 32.83%. The dividend yield is 1.81%.

Oberoi Realty: 24.40% Profit CAGR Since FY22

Oberoi Realty develops premium residential, office, retail and hotel projects, mainly in Mumbai. It reported FY26 revenue of Rs 6,304.27 crore, up 15.16% year on year, and net profit of Rs 2,507.43 crore, up 12.67%. Net profit has compounded at 24.40% a year since FY22, while revenue has grown 23.02% a year. Operating margin was 60.69% in FY26. The debt-to-equity ratio is 0.16.

The stock trades at a PE of 24.95 against an industry PE of 31.94, below the sector average, with a return on equity of 13.99%. In the June 2026 quarter, revenue rose 26.79% to Rs 1,361.69 crore and net profit grew 29.02% to Rs 543.51 crore. The share price has gained 96.94% over five years. Domestic institutions raised their holding from 10.80% in June 2025 to 14.83% in June 2026.

Narayana Health: 24.06% Profit CAGR Since FY22

Narayana Health runs a network of multi-speciality hospitals, with a strong cardiac care franchise and a presence in India and the Cayman Islands. It reported FY26 revenue of Rs 7,996.25 crore, up 43.43% year on year, and net profit of Rs 810.46 crore, up 2.61%. Net profit has compounded at 24.06% a year since FY22, while revenue has grown 20.95% a year. Operating margin was 21.25% in FY26.

In the June 2026 quarter, revenue rose 77.60% to Rs 2,719.11 crore and net profit grew 5.37% to Rs 207.27 crore. The share price has gained 236.19% over five years. Domestic institutions raised their holding from 7.76% in September 2025 to 10.68% in September 2026. The stock trades at a PE of 46.24 against an industry PE of 60.75, below the sector average, with a return on equity of 17.76%.

Endurance: Revenue Up 26.05% in FY26

Endurance Technologies makes suspension, braking, transmission and aluminium casting products for two-wheelers, three-wheelers and cars. It reported FY26 revenue of Rs 14,719.85 crore, up 26.05% year on year, and net profit of Rs 951.71 crore, up 13.79%. Net profit has compounded at 19.89% a year since FY22, while revenue has grown 18.01% a year. Operating margin was 14.17% in FY26. The debt-to-equity ratio is 0.19.

The stock trades at a PE of 37.22 against an industry PE of 37.33, below the sector average, with a return on equity of 13.91%. In the June 2026 quarter, revenue rose 29.62% to Rs 4,348.28 crore and net profit grew 8.03% to Rs 244.52 crore. Domestic institutions raised their holding from 9.06% in September 2025 to 10.48% in September 2026.

Promoter Backed Fast Revenue Growth and Profit CAGR Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these promoter backed fast revenue growth and profit CAGR stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock Revenue (Rs Cr) Net Profit (Rs Cr) Revenue Growth (YoY) 4-Year Revenue CAGR 4-Year Net Profit CAGR Operating Margin (Latest Quarter)
Nippon AMC 2,933.07 1,528.13 16.36% 17.56% 19.74% 88.41%
Oberoi Realty 6,304.27 2,507.43 15.16% 23.02% 24.40% 61.42%
Narayana Health 7,996.25 810.46 43.43% 20.95% 24.06% 18.75%
Endurance 14,719.85 951.71 26.05% 18.01% 19.89% 13.19%

Check the Univest Screener for live data on these promoter backed fast revenue growth and profit CAGR stocks

Institutional Holding in Nippon AMC, Oberoi Realty, Narayana Health and Endurance

Institutional holding shows who is backing these promoter backed fast revenue growth and profit CAGR stocks alongside the promoter. The table uses the latest reported quarter for each. Oberoi Realty has the deepest institutional backing, with FII and DII together holding 29.94% as of June 2026. Domestic institutions increased their holding over the past year in Nippon AMC (from 13.45% to 15.49%), Oberoi Realty (from 10.80% to 14.83%), Narayana Health (from 7.76% to 10.68%) and Endurance (from 9.06% to 10.48%). A useful check is to set these companies against the Nifty Midcap 100 and see which ones lead it.

Stock Promoter FII DII Public Quarter
Nippon AMC 71.80% 7.04% 15.49% 5.67% June 2026
Oberoi Realty 67.70% 15.11% 14.83% 2.36% June 2026
Narayana Health 63.27% 9.01% 10.68% 17.04% September 2026
Endurance 75.00% 12.07% 10.48% 2.45% September 2026

Risks to Weigh in Promoter Backed Fast Revenue Growth and Profit CAGR Stocks

Being careful with promoter backed fast revenue growth and profit CAGR stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

  • Past growth may not repeat.
  • Share prices can move sharply in either direction.
  • Valuation: Nippon AMC trades at a PE of 46.21 against an industry PE of 17.70, so earnings need to keep growing to support the price.
  • Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Promoter Backed Fast Revenue Growth and Profit CAGR Stocks

Picking from promoter backed fast revenue growth and profit CAGR stocks comes down to four checks, applied in order.

  1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
  2. Compare each PE with the industry PE (17.70 to 60.75) and ask whether the growth rate justifies any gap.
  3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
  4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Nippon AMC, Oberoi Realty, Narayana Health and Endurance live prices.

Conclusion

Among promoter backed fast revenue growth and profit CAGR stocks, Nippon AMC stands out for the highest return on equity at 32.83%, Oberoi Realty for the fastest profit growth, 24.40% a year since FY22, Narayana Health for the biggest five-year price gain at 236.19% and Endurance for 26.05% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing promoter backed fast revenue growth and profit CAGR stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Promoter Backed Fast Revenue Growth and Profit CAGR Stocks to Watch

Which are the best promoter backed fast revenue growth and profit CAGR stocks to watch for multibagger potential?

Ans. Nippon AMC, Oberoi Realty, Narayana Health and Endurance are the 4 names this list highlights, with market caps of Rs 75,647 crore, Rs 65,583 crore, Rs 37,763 crore and Rs 36,097 crore respectively. Nippon AMC is notable for the highest return on equity at 32.83%. Oberoi Realty stands out for the fastest profit growth, 24.40% a year since FY22. Narayana Health offers the biggest five-year price gain at 236.19%. Endurance brings 26.05% revenue growth in FY26. These are watchlist names for promoter backed fast revenue growth and profit CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Nippon AMC a good stock for long-term investors?

Ans. Nippon AMC has a return on equity of 32.83%, a PE of 46.21 against an industry PE of 17.70 and a market cap of Rs 75,647 crore. Net profit has compounded at 19.74% a year since FY22, and FY26 revenue rose 16.36% while June 2026 quarter net profit grew 27.15%. Long-term returns in promoter backed fast revenue growth and profit CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Oberoi Realty become a multibagger from here?

Ans. Oberoi Realty has already gained 96.94% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in promoter backed fast revenue growth and profit CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 24.40% a year since FY22, and FY26 revenue rose 15.16%. At a PE of 24.95 against an industry PE of 31.94, valuation should be checked against that growth before investing.

What is the market cap of Nippon AMC, Oberoi Realty, Narayana Health and Endurance?

Ans. As of 11 November 2026, Nippon AMC has a market cap of Rs 75,647 crore, Oberoi Realty has a market cap of Rs 65,583 crore, Narayana Health has a market cap of Rs 37,763 crore and Endurance has a market cap of Rs 36,097 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on promoter backed fast revenue growth and profit CAGR stocks.

What are the risks of investing in promoter backed fast revenue growth and profit CAGR stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Nippon AMC trades at a PE of 46.21 against an industry PE of 17.70, so earnings growth needs to hold up.

Why is Nippon AMC trading at a PE of 46.21?

Ans. Nippon AMC's PE of 46.21 compares with an industry PE of 17.70. The market is paying a premium for a return on equity of 32.83%, profit growth of 19.74% a year since FY22 and latest-quarter profit growth of 27.15%, which also means the stock is more sensitive if growth slows. Investors in promoter backed fast revenue growth and profit CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Nippon AMC, Oberoi Realty, Narayana Health and Endurance?

Ans. As of the latest reported quarter, FII and DII together hold 22.53% of Nippon AMC (7.04% and 15.49%), 29.94% of Oberoi Realty (15.11% and 14.83%), 19.69% of Narayana Health (9.01% and 10.68%) and 22.55% of Endurance (12.07% and 10.48%). Rising institutional holding is a useful signal in promoter backed fast revenue growth and profit CAGR stocks, though it should be read with earnings trends rather than on its own.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down